Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CIK Cells for Psoriasis
NCT01894373Phase 2Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2015
- Primary completion
- Jun 2017
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of unmodified CIK in plaque psoriasis, sponsored by Chinese PLA General Hospital. Started Jun 2015; status: completed.
02
Drugs
unmodified CIK
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01894373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01894373.